Go to content
UR Home

Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies

URN to cite this document:
DOI to cite this document:
Lord, Phillip ; Spiering, Rachel ; Aguillon, Juan C. ; Anderson, Amy E. ; Appel, Silke ; Benitez-Ribas, Daniel ; ten Brinke, Anja ; Broere, Femke ; Cools, Nathalie ; Cuturi, Maria Cristina ; Diboll, Julie ; Geissler, Edward K. ; Giannoukakis, Nick ; Gregori, Silvia ; van Ham, S. Marieke ; Lattimer, Staci ; Marshall, Lindsay ; Harry, Rachel A. ; Hutchinson, James A. ; Isaacs, John D. ; Joosten, Irma ; van Kooten, Cees ; Lopez Diaz de Cerio, Ascension ; Nikolic, Tatjana ; Oral, Haluk Barbaros ; Sofronic-Milosavljevic, Ljiljana ; Ritter, Thomas ; Riquelme, Paloma ; Thomson, Angus W. ; Trucco, Massimo ; Vives-Pi, Marta ; Martinez-Caceres, Eva M. ; Hilkens, Catharien M. U.
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 17 Mar 2020 11:29


Cellular therapies, with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation The methodologies for generating tolAPC vary greatly between different laboratories, making it difficult to compare data from different studies; thus constituting a major hurdle for the ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons